Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Low-Volume Blood Products Set For Payment Increase Under 2005 OPPS

This article was originally published in The Gray Sheet

Executive Summary

CMS will raise payments for low-volume blood product APCs in 2005 in response to stakeholder comments that the proposed rates were too low

You may also be interested in...



Blood Product Payment Rates Should Be Higher, APC Panel Agrees

Maintaining a safe and adequate blood supply requires sufficient reimbursement for blood and blood products, according to CMS' Ambulatory Payment Classification advisory panel

Blood Product Payment Rates Should Be Higher, APC Panel Agrees

Maintaining a safe and adequate blood supply requires sufficient reimbursement for blood and blood products, according to CMS' Ambulatory Payment Classification advisory panel

Blood Products Should Be Frozen At 2004 Rates – APC Advisory Panel

Blood testing technology advances have spurred higher costs for blood centers without a corresponding jump in reimbursement, stakeholders informed the APC Advisory Panel in Baltimore Sept. 1

UsernamePublicRestriction

Register

OM002075

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel